6640--CTX Microbiology Automation System w/TAA
Veterans Affairs · 257-NETWORK CONTRACT OFFICE 17 (36C257)
Capture briefs (a one-page, shareable copy of this page) are part of Pro. The CSV here holds the notice, its timeline and past awards.
Where this opportunity stands
Every notice posted under solicitation 36C25725Q0794 in this department, oldest first.
Next steps for this stage
Standard steps for the notice type; not advice about this buyer.
- Decide bid or no bid before the response deadline.
- Look at the past winners for likely competitors and teaming partners.
- Follow the opportunity to hear about amendments and the award.
What the notice says
This solicitation is issued as unrestricted 36C25725Q0794 This is a combined synopsis/solicitation for commercial products or commercial services prepared in accordance with the format in subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; quotations are being requested and a written solicitation will not be issued. The solicitation number 36C25725Q0794 is issued as a request for quotation (RFQ). The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Ci… (show all)
rcular 2025-04. The NAICS Code for this request for quotes is 334516 - Analytical Laboratory Instrument Manufacturing 1000 employees. Central Texas Veterans Health Care System, Pathology/Laboratory Medicine. The requirement is for Microbiology Automation System. See attached solicitation document for more information. Provision 52.212-1, Instructions to Offerors-Commercial Products and Commercial Services, applies to this acquisition. Provision 52.212-2, Evaluation-Commercial Products and Commercial Services, applies to this acquisition. Offerors must complete the provision 52.212-3, Offeror Representations and Certifications-Commercial Products and Commercial Services, with this offer. Clause 52.212-4, Contract Terms and Conditions-Commercial Products and Commercial Services, applies to this acquisition. Clause 52.212-5, Contract Terms and Conditions Required to Implement Statutes or Executive Orders-Commercial Products and Commercial Services, applies to this acquisition and any additional contract requirement(s) or terms and conditions (such as contract financing arrangements or warranty requirements) determined by the contracting officer to be necessary for this acquisition and consistent with customary commercial practices. Late quotes or documentation may be accepted if advantageous to the Government. All comments or inquiries are to be submitted in writing via email to the Point of Contact, referenced in this notice on or before July 25, 2025, 10:00 AM Central Time. Vendors interested in providing the required products will need to submit all required documentation, detailed in the attached solicitation document, by email to Jose Campa at Jose.Campa@va.gov, no later than Thursday, July 31, 2025, 1:00 PM Central Time.
Who won similar work
10 award notices on SAM.gov in the last 24 months. Matched by: Same office (257-NETWORK CONTRACT OFFICE 17 (36C257)), same product/service code (PSC) 6640 and NAICS 334516.
Single-winner award sizes (8): middle half $221K to $528K, median $283K; range $40K to $1.6M.
| Winner | Awards | Value | Last |
|---|---|---|---|
| ABBOTT LABORATORIES INC. · $ABT · $45.1B | 2 | $1.9M | Jun 24, 2025 |
| BECKMAN COULTER, INC | 2 | $1.3M | Jan 28, 2026 |
| CEPHEID SUNNYVALE 94089 | 1 | $333K | May 15, 2026 |
| AGILENT TECHNOLOGIES, INC. · $A · $7.4B | 1 | $295K | Jul 14, 2026 |
| GOVERNMENT SCIENTIFIC SOURCE INC | 1 | $271K | Feb 18, 2026 |
| POLYMEDCO CANCER DIAGNOSTIC PRODUCTS LLC | 1 | $40K | Jan 28, 2025 |
| ORTHO-CLINICAL DIAGNOSTICS, INC · $QDEL · $2.7B | 1 | – + 1 shared | May 20, 2025 |
| WERFEN USA LLC | 1 | – + 1 shared | May 15, 2025 |
Value counts new single-winner awards. "Shared" awards are multiple-award contracts that list every winner with the same total ceiling (same contract, or the same office, day and amount); that ceiling is not one company's win, so it is not added in. Contract modifications are not new awards and are not added in either. Revenue next to a ticker is the company's revenue over the latest 12 months in its SEC filings.
- $ABT reported $45.1B revenue (12 months to Mar 31, 2026). The median single-winner award in these 8 past awards, $283K, is under 0.1% of that. SEC filing
- $A reported $7.4B revenue (12 months to Jul 31, 2026). The median single-winner award in these 8 past awards, $283K, is under 0.1% of that. SEC filing
- $QDEL reported $2.7B revenue (12 months to Jun 28, 2026). The median single-winner award in these 8 past awards, $283K, is under 0.1% of that. SEC filing
One award's total value against one year of revenue; many awards are paid over several years.
- Jul 14, 2026AGILENT TECHNOLOGIES, INC.$295K6640--NEW - Seahorse XF Pro Analyzer - Laboratory InstrumentationMateriality: <0.01% of $A revenue (Low) SEC
- May 15, 2026CEPHEID SUNNYVALE 94089$333K6640--Molecular Diagnostic SystemNo listed company matched (Materiality N/A)
- Feb 18, 2026GOVERNMENT SCIENTIFIC SOURCE INC$271K6640--CTX Immunoassay Random Access Multiplex AnalyzerNo listed company matched (Materiality N/A)
- Jan 28, 2026BECKMAN COULTER, INC$1.1M6640--NEW - Automated Hematology CPRR and InstrumentationNo listed company matched (Materiality N/A)
- Sep 16, 2025BECKMAN COULTER, INC$171K6640--STVHCS Microscan MALDI Cost Per TestNo listed company matched (Materiality N/A)
- Jun 24, 2025ABBOTT LABORATORIES INC.$1.6M6640--Immunoassay CPRR (HIV, HEP, Tacrolimus)Materiality: <0.01% of $ABT revenue (Low) SEC
- May 20, 2025ORTHO-CLINICAL DIAGNOSTICS, INC$334K (shared ceiling)6640--STVHCS - Automated Blood Bank Analyzer - Cost Per TestShared multiple-award ceiling, not one company's win (Materiality N/A)
- May 15, 2025WERFEN USA LLC$334K (shared ceiling)6640--STVHCS - Automated Blood Bank Analyzer - Cost Per TestShared multiple-award ceiling, not one company's win (Materiality N/A)
- Feb 24, 2025ABBOTT LABORATORIES INC.$238K6640--NEW - VCB Automation Line Bridge 3mo+3moMateriality: <0.01% of $ABT revenue (Low) SEC
- Jan 28, 2025POLYMEDCO CANCER DIAGNOSTIC PRODUCTS LLC$40K6640--El Paso Lab OC-Sensor Diana Analyzer - PolymedcoNo listed company matched (Materiality N/A)
Materiality: one award's value as a share of the winner's revenue over the latest 12 months in its SEC filings (or its last fiscal year, as noted when you point at it). Low under 1%, Medium 1 to 5%, High 5% or more. Many awards are paid over several years, so this overstates a single year's share.
Competitive landscape
For the 8 most frequent past winners above. Lobbying is matched by the company's exact name or exact ticker; agencies are as named on the filings.
- 1 of these past winners lobbied Veterans Affairs, Dept of (VA) since 2024 (5 filings)
- 0 of their lobbyists list a past Veterans Affairs, Dept of (VA) job
- $48K from their corporate PACs since 2024 to members of House Committee on Appropriations, House Committee on Veterans' Affairs, Senate Committee on Appropriations, Senate Committee on Veterans' Affairs
- 0 foreign-agent (FARA) registrations
Policy around it
Bills the past winners named while lobbying this agency's issues, rules from the department, and executive orders that name the agency, last 12 months.
- 5 bills named on the past winners' lobbying filings
- 25 rules from the department in the last 12 months
- 0 executive orders naming the agency in the last 12 months
Market
For past winners matched exactly to a listed company. Insider trades are open-market buys and sells (Form 4) in the last 90 days, shown as facts; our own study found insiders do not reliably buy ahead of awards. A sale marked 10b5-1 was made under a trading plan set up in advance.
- 3 of the past winners are listed companies
- 0 insider buys and 3 insider sells at them in the last 90 days
Sources: SAM.gov notices and award notices; Senate LDA lobbying filings; FEC filings; FARA; Federal Register; congress.gov; SEC Form 4. Every row above links to its record.
Companies are matched to tickers by exact name, including the subsidiaries a company lists in its SEC filings. A company we could not match shows no market rows; that is a miss, not a finding.